Obesity and Metabolism Unit, Department of Endocrinology, Singapore General Hospital, 20 College Road, Singapore 169856.
Clinical Obesity Research, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia.
Nat Rev Gastroenterol Hepatol. 2017 Sep;14(9):553-564. doi: 10.1038/nrgastro.2017.80. Epub 2017 Jul 12.
Obesity is a major public health concern that leads to numerous metabolic, mechanical and psychological complications. Although lifestyle interventions are the cornerstone of obesity management, subsequent physiological neurohormonal adaptations limit weight loss, strongly favour weight regain and counteract sustained weight loss. A range of effective therapies are therefore needed to manage this chronic relapsing disease. Bariatric surgery delivers substantial, durable weight loss but limited access to care, perceived high risks and costs restrict uptake. Medical devices are uniquely positioned to bridge the gap between more conservative lifestyle intervention and weight-loss pharmacotherapy and more disruptive bariatric surgery. In this Review, we examine the range of gastrointestinal medical devices that are available in clinical practice to treat obesity, as well as those that are in advanced stages of development. We focus on the mechanisms of action as well as the efficacy and safety profiles of these devices. Many of these devices are placed endoscopically, which provides gastroenterologists with exciting opportunities for treatment.
肥胖是一个主要的公共卫生关注点,它会导致许多代谢、机械和心理并发症。尽管生活方式干预是肥胖管理的基石,但随后的生理神经激素适应会限制体重减轻,强烈有利于体重反弹,并抵消持续的体重减轻。因此,需要一系列有效的治疗方法来管理这种慢性复发性疾病。减重手术能带来显著且持久的体重减轻,但由于获得医疗服务的机会有限,以及对高风险和高成本的认知,限制了其应用。医疗设备在更保守的生活方式干预和减肥药物治疗与更具破坏性的减重手术之间具有独特的优势。在这篇综述中,我们研究了目前临床实践中用于治疗肥胖症的一系列胃肠道医疗设备,以及那些处于高级开发阶段的设备。我们重点介绍了这些设备的作用机制以及疗效和安全性特征。这些设备中的许多都是通过内窥镜放置的,这为胃肠病学家提供了令人兴奋的治疗机会。